News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 181–216
- Matches
- 616
- Sources here
- 17
- Companies here
- 20
Search results
Stored financial headlines
Active search
616 matching headlines
Ticker or company: RGENMain company stories
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Emergent BioSolutions Inc. 2026 Q2 - Results - Earnings Call Presentation (NYSE:EBS) 2026-08-05
Key Points Interested in Emergent Biosolutions Inc.? Here are five stocks we like better. Q2 performance exceeded expectations: Revenue reached $234 million and adjusted EBITDA rose to $97 million, driven by accelerated medical countermeasure deliveries and strong U.S. government contract activity. NARCAN competition is …
EBS
main company
Sharemaestro market context
Price below Trend Line
52 weeks -50.3% · Next-week setup negative 43.4%
Emergent BioSolutions Reports Second Quarter 2026 Financial Results
Emergent BioSolutions announced its second-quarter 2026 financial results, reporting total revenues of $234.3 million, a 66% increase year-over-year, and an adjusted net income of $30.9 million, up 134%. Despite a significant net loss due to a non-cash impairment charge, the company is implementing a …
EBS
main company
Sharemaestro market context
Price below Trend Line
52 weeks -50.3% · Next-week setup negative 43.4%
Emergent records $191.3M non-cash charge related to NARCAN asset group
Emergent BioSolutions reported Q2 2026 total revenues of $234.3 million, a 66% increase year-over-year, driven primarily by higher U.S. government sales of smallpox and other medical countermeasure products. Despite this revenue growth and improved adjusted net income and EBITDA, the company posted a GAAP …
EBS
main company
Sharemaestro market context
Price below Trend Line
52 weeks -50.3% · Next-week setup negative 43.4%
California State Teachers Retirement System Raises Holdings in Repligen Corporation $RGEN
The California State Teachers Retirement System increased its stake in Repligen Corporation (NASDAQ:RGEN) by 22.1% in the first quarter, now holding 61,860 shares valued at $7.3 million. Repligen exceeded analyst expectations with quarterly revenue of $204.13 million and earnings of $0.54 per share, and …
RGEN
main company
Sharemaestro market context
Trend signal active
52 weeks +33.7%
Emergent BioSolutions Commits to Cross-Sector Collaboration Against Biological Threats in an Evolving Global Security Environment
Emergent BioSolutions (NYSE: EBS) emphasizes the critical need for cross-sector collaboration to address evolving biological threats stemming from geopolitical conflicts, AI, and synthetic biology. The company highlights calls from European health officials and AI industry leaders for stronger safeguards and points to recent anthrax-related …
EBS
main company
Sharemaestro market context
Price below Trend Line
52 weeks -50.3% · Next-week setup negative 43.4%
Telecom Argentina SA Class B Revenue Breakdown – BCBA:TECO2
Telecom Argentina SA Class B (BCBA:TECO2) generated 8.33 trillion ARS last year, with its Information and Communications Technology Services segment contributing 5.28 trillion ARS. The majority of the company's revenue, 8.03 trillion ARS, originated from Argentina.
Sharemaestro market context Trend signal active 52 weeks +72.2%Lithium Argentina Closes $220M Debt Facilities | LAR Stock News
Lithium Argentina (LAR) has secured $220 million in new unsecured debt facilities for its Cauchari-Olaroz lithium brine operation, aimed at funding a Stage 2 expansion to add 45,000 tonnes per annum of lithium carbonate equivalent production. The financing includes a $50 million two-year facility …
LAR
main company
Sharemaestro market context
Price below Trend Line
52 weeks +111.8%
Lithium Argentina Announces $220 Million of New Debt Facilities Closed at Cauchari-Olaroz
Lithium Argentina announced the closing of $220 million in new unsecured debt facilities for its Cauchari-Olaroz lithium brine operation. These facilities, consisting of a $50 million and a $170 million credit line, will strengthen the company's financial position and provide funding flexibility for its …
LAR
main company
Sharemaestro market context
Price below Trend Line
52 weeks +111.8%
Moody National Bank Trust Division Makes New Investment in Repligen Corporation $RGEN
Moody National Bank Trust Division has acquired a new stake in Repligen Corporation (NASDAQ:RGEN), purchasing 17,728 shares valued at approximately $2.42 million. This investment comes as institutional investors collectively own 97.64% of the biotechnology company. Repligen recently reported strong quarterly earnings, exceeding analyst expectations …
RGEN
main company
Sharemaestro market context
Trend signal active
52 weeks +33.7%
Earnings call transcript: Emergent BioSolutions Q2 2026 revenue tops guidance
This article provides the Q2 2026 earnings report for Emergent BioSolutions. It is a quarterly filing (10-Q) that details the company's financial performance during the second quarter of 2026.
EBS
main company
Sharemaestro market context
Price below Trend Line
52 weeks -50.3% · Next-week setup negative 43.4%
(BBVA) as a Liquidity Pulse for Institutional Tactics
This article provides an AI-driven analysis of Banco Bilbao Vizcaya Argentaria S.a. (NASDAQ: BBVA), highlighting strong sentiment across all time horizons and compelling upside potential due to the absence of resistance levels above the current price. It outlines specific institutional trading strategies, including long, …
BBVA
main company
Sharemaestro market context
Trend signal active
52 weeks +57.5% · Next-week setup positive 65.1%
What Makes Argenx (ARGX) a New Buy Stock
Investors might want to bet on argenex SE (ARGX), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices. …
Sharemaestro market context Trend signal active 52 weeks +23.7% · Next-week setup negative 39.6%Argenx SE (ARGX) Prepares to Demonstrate Vyvgart’s Efficacy in Broader Autoimmune Diseases
Baron Capital, an investment management company, released its Q2 2026 investor letter for the "Baron Health Care Fund". A copy of the letter is available to download here. The Fund gained 11.99% during the quarter, compared with the 10.48% gain for the Russell 3000 …
Sharemaestro market context Trend signal active 52 weeks +23.7% · Next-week setup negative 39.6%BBVA Closes EUR1.5 Billion Share Buyback Tranche
BBVA has successfully completed a share buyback program totaling EUR1.5 billion. This action is part of the bank's strategy to return capital to shareholders. The buyback involved the acquisition of a significant number of shares, which are expected to be cancelled.
BBVA
main company
Sharemaestro market context
Trend signal active
52 weeks +57.5% · Next-week setup positive 65.1%
Certain Class B Common Stock of Forgent Power Solutions, Inc. are subject to a Lock-Up Agreement Ending on 4-AUG-2026.
Certain Class B Common Stock of Forgent Power Solutions, Inc. will be subject to a lock-up agreement ending on August 4, 2026. This lock-up period, lasting 181 days, prevents company officers, directors, and Continuing Equity Owners from selling or otherwise disposing of these shares …
FPS
main company
Sharemaestro market context
Stored weekly price path
28 weeks +17.5% · Next-week setup positive 55.4%
Repligen Corporation (BLFS) sets cash and stock terms for BioLife Solutions buyout
Repligen Corporation has announced an agreement to acquire BioLife Solutions for a combination of cash and stock. BioLife shareholders will receive $11.25 in cash plus 0.1442 shares of Repligen common stock for each BioLife share. The transaction, described as a strategic combination in the …
RGEN
main company
Sharemaestro market context
Trend signal active
52 weeks +33.7%
Emergent BioSolutions Inc expected to post earnings of 11 cents a share - Earnings Preview
Emergent BioSolutions Inc. (EBS) is expected to announce earnings of 11 cents per share. This information comes from a Refinitiv earnings preview. The full article is available through TradingView News, which offers access to Reuters and other news sources.
EBS
main company
Sharemaestro market context
Price below Trend Line
52 weeks -50.3% · Next-week setup negative 43.4%
BioLife Solutions (NASDAQ: BLFS) shares Repligen merger video with staff
BioLife Solutions (NASDAQ: BLFS) has informed its employees about its pending merger with Repligen Corporation, distributing an internal email with a video from Repligen's CEO. The video introduces Repligen and discusses the anticipated benefits of the combination, particularly growth opportunities in the cell therapy …
RGEN
main company
Sharemaestro market context
Trend signal active
52 weeks +33.7%
argenx (ARGX) calls September 17 EGM to add two non-executive directors
argenx SE has announced an Extraordinary General Meeting of Shareholders (EGM) for September 17, 2026, in Amsterdam. The primary purpose of the EGM is to vote on the proposed appointments of Mr. Thomas M. Brakel and Mr. Khurem Farooq as non-executive directors to the …
ARGX
main company
Sharemaestro market context
Trend signal active
52 weeks +29.0% · Next-week setup positive 56.3%
argenx announces Extraordinary General Meeting of Shareholders on September 17, 2026
argenx SE August 3, 2026 – 22:01 PM CEST Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology innovation company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that the Extraordinary General Meeting of …
Sharemaestro market context Trend signal active 52 weeks +29.0% · Next-week setup positive 56.3%Is Loma Negra Compañía Industrial Argentina Sociedad Anónima (LOMA) Fully Valued At $11.48?
Loma Negra (LOMA) stock is trading at $11.48, which analysts consider a clear discount to targets but a significant premium to some intrinsic estimates. The company's Price-to-Earnings (P/E) ratio of 55.1x is substantially higher than its peer average of 20.4x and the global Basic …
Sharemaestro market context Trend signal ended 52 weeks +9.3%Banco BBVA Argentina SA's Dividend Analysis
This article first appeared on GuruFocus. Evaluating the Upcoming Payout and Long-Term Sustainability Banco BBVA Argentina SA (NYSE:BBAR) recently announced a total dividend of $0.08 per share, with the ex-dividend date set for 2026-08-03. This upcoming payment includes a cash dividend of $0.08 per …
Sharemaestro market context Trend signal active 52 weeks +34.3% · Next-week setup positive 57.2%How Repligen Corporation (RGEN) Affects Rotational Strategy Timing
This article analyzes Repligen Corporation (RGEN) using AI models to offer trading strategies. It highlights a strong near-term sentiment with a neutral mid- and long-term outlook, identifying an exceptional risk-reward setup. The analysis provides specific entry, target, and stop-loss levels for position, momentum, and …
RGEN
main company
Sharemaestro market context
Trend signal active
52 weeks +33.7%